The high prevalence of fascin immunoreactivity in NSCLC (as opposed to the lack of staining of nonneoplastic epithelia of the lower respiratory tract) and its significant relation with tumour recurrence and reduced patient survival emphasise the possible involvement of this protein in the development and progression of NSCLC. This evidence concerns the gene FSCN1 and neoplasm.